HRT Financial’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
HRT Financial's BLTE Position: Q3 2026 in Review
HRT Financial opened a new position in Belite Bio (BLTE) in Q3 2026: 5,259 shares worth $893K. The stake represents ﹤0.01% of the portfolio and ranks #2467 among its holdings. This is a return to the name: HRT Financial previously reported a position in BLTE as recently as Q1 2026.
HRT Financial first reported a position in BLTE in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.74M in Q1 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- HRT Financial held 5,259 shares of Belite Bio worth $893K as of Q3 2026.
- Belite Bio was a new HRT Financial position in Q3 2026.
- Belite Bio made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #2467 holding.
- HRT Financial first reported a position in Belite Bio in Q2 2024 and has held it in 5 quarters since.
- HRT Financial's Belite Bio position peaked at $1.74M in Q1 2026.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.